Beta-2-microglobulin: a valuable parameter of stage, prognosis and response to treatment in myelomatosis.
D006801:Humans; D009101:Multiple Myeloma / Q000097:blood / Q000473:pathology / Q000628:therapy; D009367:Neoplasm Staging; D011379:Prognosis; D001613:beta 2-Microglobulin / Q000378:metabolism*
D001613:beta 2-Microglobulin